YAP1 and ovarian carcinoma: In this study, we demonstrate that miR-129-5p directly inhibits YAP and TAZ expression, which leads to the inactivation of TEAD and subsequent inhibition of ovarian cancer cell proliferation, survival and tumorigenicity.